COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report

MeSH terms

• Adrenergic alpha-2 Receptor Agonists / therapeutic use*
• Aged
• Analgesics, Opioid / adverse effects
• Antipsychotic Agents / therapeutic use*
• Azepines / therapeutic use
• Betacoronavirus
• COVID-19
• Central Nervous System Depressants / therapeutic use
• Chlordiazepoxide / adverse effects
• Coronavirus Infections / complications
• Coronavirus Infections / physiopathology
• Coronavirus Infections / psychology
• Coronavirus Infections / therapy*
• Delirium / drug therapy*
• Delirium / etiology
• Delirium / physiopathology
• Delirium / psychology
• Dexmedetomidine / adverse effects
• Female
• Guanfacine / therapeutic use
• Haloperidol / therapeutic use
• Humans
• Hydromorphone / adverse effects
• Hypnotics and Sedatives / adverse effects*
• Intensive Care Units
• Ketamine / adverse effects
• Melatonin / therapeutic use
• Midazolam / adverse effects
• Oxycodone / adverse effects
• Pandemics
• Pneumonia, Viral / complications
• Pneumonia, Viral / physiopathology
• Pneumonia, Viral / psychology
• Pneumonia, Viral / therapy*
• Propofol / adverse effects
• Psychomotor Agitation / drug therapy*
• Psychomotor Agitation / etiology
• Psychomotor Agitation / physiopathology
• Psychomotor Agitation / psychology
• Respiration, Artificial
• SARS-CoV-2
• Sleep Aids, Pharmaceutical / therapeutic use*
• Sleep Disorders, Circadian Rhythm / drug therapy
• Sleep Disorders, Circadian Rhythm / etiology
• Sleep Disorders, Circadian Rhythm / physiopathology
• Tracheostomy
• Triazoles / therapeutic use
• Valproic Acid / therapeutic use